pharmaceutical investing DelMar Pharmaceuticals Receives IND Allowance from FDA to Initiate Clinical Trials of VAL-083 for the Treatment of Ovarian Cancer
Q Biomed Inc. Finalizes License Agreement With Oklahoma Medical Research Foundation And The Rajiv Gandhi Centre For Biotechnology For Novel Liver Cancer Treatment
Syntholene Engages Imperial College of London Expert for Independent Technical Review of Operating Data from Iceland Demonstration Facility
NextSource Materials Secures Binding Agreement for US$30 Million Strategic Investment from Japan's Hanwa and JOGMEC to Advance its UAE Battery Anode Facility
